「Melioidosis」の版間の差分

提供: Vaccipedia | Resources for Vaccines, Tropical medicine and Travel medicine
ナビゲーションに移動 検索に移動
32行目: 32行目:
 
*especially diabetes mellitus and chronic renal failure
 
*especially diabetes mellitus and chronic renal failure
 
**steroid, alcohol abuse, liver dysfunction, chronic lung disease, etc.
 
**steroid, alcohol abuse, liver dysfunction, chronic lung disease, etc.
 +
*HIV never predisposes to melioidosis
  
 
==clinical course==
 
==clinical course==

2021年5月30日 (日) 21:31時点における版

Navigation Menu Vac logo.png
General issues of Vaccine
Cold chain
Correlates of Protection
Vaccines for Asplenia
Vaccines for Pregnant women
Vaccines for Immunocompromised hosts
Vaccine hesitancy
Additional materials of vaccine
General issues of Tropical med.
Definition of Tropical Medicine
Matrices of tropical infection
General issues of Helminths
Neglected Tropical Diseases
Sexually-transmitted infections
Non-Communicable Diseases
Maternal health and contraception
Child health
Malnutrition and Micronutrient
Eosinophilia
Fever in the tropics
Diarrhea in the tropics
Anemia in the tropics
Dermatology in the tropics
Ophthalmology in the tropics
Neurology in the tropics
Mental health in the tropics
Surgery in the tropics
Humanitarian emergency
Epidemiology in outbreak
Antimicrobial resistance
Pathology of infectious diseases
General issues of Travel med.
Epidemiology of Travel health
Last minute traveler
Time zone issue
High altitude medicine
Diving medicine
Pregnancy and travel
Children and travel
Elderly and travel
Immunology
Principle of human immune system
Innate immunity
Cellular immunity
Humoral immunity
Neutralizing antibody and its assay
Antigenic Cartography
Additional materials of immunology
Epi & Stats
Basics & Definition
Epidemiology
Odds in statistics and Odds in a horse race
Collider bias
Data distribution
Statistical test
Regression model
Multivariate analysis
Marginal effects
Prediction and decision
Table-related commands in STATA
Missing data and imputation
Virus
HIV
HIV-TB co-infection
HIV-STI interaction
Viral Hemorrhagic Fever
Ebola
Crimean-Congo hemorrhagic fever
SFTS
Rabies
Polio
Dengue
Yellow fever
Chikungunya
Zika
Japanese encephalitis
Tick-borne encephalitis
Viral hepatitis
Measles
Smallpox and Monkeypox
Respiratory Syncytial virus
COVID-19
Bivalent BA.1/BA.4-5 mRNA vaccines
Monovalent XBB-1.5 mRNA vaccine
Private archives of the initial phase of the pandemic
Private archives of lecture materials of COVID vaccine as of March 2021
厚生労働省が発出する保健行政関連の文書の読み解き方
Bacteria
Bacteriological tests
Tuberculosis
Tuberculosis in Children
HIV-TB co-infection
Leprosy
Dermatological mycobacterium infecions
Syphilis and Yaws
Plague
Pneumococcus
Meningococcus
Typhoid
Salmonellosis
Melioidosis
Leptospirosis
Brucellosis
Bartonellosis
Lyme disease and Relapsing fever
Tularaemia
Tetanus
Diphtheria
Anthrax
Coxiellosis
Rickettsia
Rickettsiosis
Scrub typhus
Spotted fevers
Epidemic typhus
Murine typhus
Protozoa
Overview of protozoa
Overview of medicine for protozoa
Malaria
Chagas disease
African trypanosomiasis
Leishmaniasis
Trichomoniasis
Toxoplasmosis
Amoebiasis
Giardiasis
Cryptosporidiosis
Cyclosporiasis
Isosporiasis
Pentatrichomoniasis
Microsporidiasis
Babesiosis
Fungi
General issues of fungi
Coccidioidomycosis
Paracoccidioidomycosis
Histoplasmosis
Talaromycosis
Blastomycosis
Sporotrichosis
Nematode (roundworm)
Nematode principles
Lympatic filariasis
Onchocerciasis
Loiasis
Microscopic differentiation of microfilariae
Strongyloidiasis
Ascariasis
Ancylostomiasis (hookworm)
Trichuriasis (whipworm)
Enterobiasis (pinworm)
Angiostrongyliasis (rat lungworm)
Dracunculiasis (Guinea worm)
Anisakiasis
Trichinellosis (Trichinosis)
Gnathostomiasis
Spirurinasis
Soil-transmitted helminths
Trematode (fluke, distoma)
General issues of Helminths
Trematode principles
Schistosomiasis
Clonorchiasis
Fascioliasis
Paragonimiasis
Metagonimiasis
Cestode (tapeworm)
General issues of Helminths
Cestode principles
Diphyllobothriasis
Sparganosis
Taeniasis
Echinococcosis
Medical Zoology
Zoonosis
Insectology
Mosquitology
Acarology
Batology
Snake toxicology
Scorpion and spider toxicology
Marine toxicology

Chevron-up-blue.png

pathogen

  • Burkholderia pseudomallei
  • potential biological weapon

epidemiology

  • endemic South Asia, Southeastern Asia and Australia
    • especially in Northeastern Thailand and Northern Australia
    • Third ID death in Northeaster Thailand following after HIV and TB
  • reason of localized distributions are unknown
  • highly seasonal, most in rainy season
    • stormy weather events like typhoon

transmission

  • Burkholderia pseudomallei lives in soil and water
  • close and repetitive contact to soil and freshwater, especially occupationally
    • rice farmers in Thailand, Aboriginals in Australia
  • most of cases unclear contact history
  • immersion in freshwater or aspiration of freshwater like in tsunami may cause infection
  • outbreak case mediated by contaminated water supply, disinfectant or detergents

incubation period

  • 1-21 days after apparent exposure
    • mean 9 days
  • rarely long latency
    • a case of 62 years after exposed in Viet Nam
      • "Vietnamese time-bomb"

risk factors

  • 60-90% of cases have underlying conditions
  • especially diabetes mellitus and chronic renal failure
    • steroid, alcohol abuse, liver dysfunction, chronic lung disease, etc.
  • HIV never predisposes to melioidosis

clinical course

  • peak in 40-60 y/o
  • male > female, presumably difference of exposure activity
  • most asymptomatic or mild non-specific
    • 60-70% of endemic area population show seroconversion until 4 y/o
  • apparent case shows sepsis with fever and rigor
    • 80% of apparent cases have pneumonia
      • widespread consolidations or cavitations
        • mimics TB
  • altered mental status
  • jaundice
  • diarrhea
  • widespread metastatic abscesses
    • liver, spleen, parotid gland, prostate in male, cutaneous, subcutaneous, keratitis
    • parotid abscess common in children in Thailand
    • hepatosplenic abscess common in Thailand
    • prostatic abscess common in Australia

diagnosis

  • Culture only
    • oxidase positive gram negative rods resistant to aminoglycosides but susceptible to co-amoxiclav should be assumed as B. pseudomallei until proven otherwise
  • serological or molecular test have low sensitivity and low specificity
  • unevenly stained gram negative bipolar bacilli

treatment

  1. 2 weeks intensive parenteral antimicrobial
  • ceftazidime or meropenem IV
  1. 12-20 weeks eradicative oral antimicrobial
  • co-trimoxazole or co-amoxicluv PO

prognosis

  • mortality of severe mellioidosis 40% in Thailand, 14% in Australia
    • deaths within 48hrs after hospitalization common
    • less mortal without underlying condition
  • treatment response slow
    • mean 9 days fever
  • reinfection in 1-3.4% of survivors in long-term followup